Patients at risk of transmitting Tay-Sachs or fragile X:
Reprogenetics is collaborating with an IVF clinic in the Philadelphia area which is offering free medications for 30 IVF cycles requiring PGD for Tay-Sachs disease and fragile X syndrome. Interested couples should contact Ms. Jill Fischer, Genetic Counselor, at Reprogenetics at 973-436-5015.
Patients seeking PGD in Latin America:
Reprogenetics is seeking patients interested in enrolling in a randomized clinical trial to determine if full screening of embryos for all chromosome abnormalities and the selection of normal embryos for transfer can improve ongoing pregnancy rates following IVF. Patients will be allocated to one of two groups: the first group will be offered screening for eight chromosomes (including the chromosome responsible for Down syndrome) and the second group will be offered screening for all chromosomes using array CGH. The PGD test as well as ovarian stimulation drugs will be offered free of charge if the cycle is performed in Lima, Peru. Interested couples can contact Dr. Luis Noriega at +511 (434) 2130 or luis.noriega@fertilidadperu.com.
Patients seeking PGD in UK:
Reprogenetics is seeking patients interested in enrolling in a randomized clinical trial to determine if the analysis of all chromosome abnormalities in embryos and the selection of normal embryos can improve ongoing pregnancy rates following IVF. Patients will be allocated to one of two groups: IVF without PGD or IVF with PGD. The PGD test as well as ovarian stimulation drugs will be offered free of charge if the cycle is performed in the UK. Interested couples can contact Dr. Dagan Wells at Dagan.Wells@obs-gyn.ox.ac.uk.
Patients seeking PGD in Germany:
Reprogenetics is seeking patients interested in enrolling in a randomized clinical trial to determine if the analysis of all chromosome abnormalities in eggs and the selection of normal eggs can improve ongoing pregnancy rates following IVF. Patients will be allocated to one of two groups: The first group will be offered screening of eight chromosomes (including the chromosome responsible for Down syndrome) and the second group will be offered screening of all chromosomes using array CGH. Interested couples can contact Dr. Karsten Held at held@genteq.de.